Association between ratio of serum eicosapentaenoic acid to arachidonic acid and risk of cardiovascular disease: The Hisayama Study

被引:105
作者
Ninomiya, Toshiharu [1 ,2 ]
Nagata, Masaharu [2 ]
Hata, Jun [1 ,2 ]
Hirakawa, Yoichiro [2 ]
Ozawa, Mio [2 ]
Yoshida, Daigo [2 ]
Ohara, Tomoyuki [2 ,3 ]
Kishimoto, Hiro [2 ]
Mukai, Naoko [2 ]
Fukuhara, Masayo [2 ]
Kitazono, Takanari [1 ]
Kiyohara, Yutaka [2 ]
机构
[1] Kyushu Univ, Grad Sch Med Sci, Dept Med & Clin Sci, Fukuoka 8128582, Japan
[2] Kyushu Univ, Grad Sch Med Sci, Dept Environm Med, Fukuoka 8128582, Japan
[3] Kyushu Univ, Grad Sch Med Sci, Dept Neuropsychiat, Fukuoka 8128582, Japan
关键词
Eicosapentaenoic acid; Cardiovascular disease; Prospective cohort study; High sensitivity C-reactive protein; POLYUNSATURATED FATTY-ACIDS; CORONARY-HEART-DISEASE; ACUTE MYOCARDIAL-INFARCTION; PLACEBO-CONTROLLED TRIAL; WEST-COAST ESKIMOS; DOCOSAHEXAENOIC ACID; FISH CONSUMPTION; DOUBLE-BLIND; ATHEROSCLEROTIC PLAQUES; SECONDARY-PREVENTION;
D O I
10.1016/j.atherosclerosis.2013.09.023
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: We examined the association between the ratio of serum eicosapentaenoic acid to arachidonic acid (EPA/AA) or the docosahexaenoic acid (DHA)/AA and the development of cardiovascular disease in a general Japanese population. Methods: A total of 3103 community-dwelling Japanese individuals aged >= 40 years were followed up for an average of 5.1 years. Serum EPA/AA ratios were categorized into quartiles. The risk estimates were computed using a Cox proportional hazards model. Results: During the follow-up period, 127 subjects experienced cardiovascular events. Age-and sexadjusted incidence rates of cardiovascular disease increased with lower serum EPA/AA ratios in individuals with high-sensitivity C-reactive protein (HS-CRP) of >= 1.0 mg/L (p for trend 0.006), whereas no clear association was observed in those with HS-CRP of < 1.0 mg/L (p for trend 0.27). The multivariable-adjusted risk of cardiovascular disease increased significantly, by 1.52 times (95% confidence interval 1.12-2.04) per 0.20 decrement in serum EPA/AA ratio in subjects with HS-CRP of >= 1.0 mg/ L. A lower serum EPA/AA ratio was significantly associated with an increased risk of coronary heart disease, but there was no evidence of an association with stroke. The magnitude of the influence of the serum EPA/AA ratio on the cardiovascular risk increased significantly with elevating HS-CRP levels taken as a continuous variable (p for heterogeneity 0.007). However, no such association was observed for DHA/AA ratio. Conclusion: Our findings suggest that a lower serum EPA/AA ratio is associated with a greater risk of cardiovascular disease, especially coronary heart disease, among subjects with higher HS-CRP levels in the general Japanese population. (C) 2013 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:261 / 267
页数:7
相关论文
共 42 条
[31]   FISH CONSUMPTION AND MORTALITY FROM CORONARY HEART-DISEASE [J].
NORELL, SE ;
AHLBOM, A ;
FEYCHTING, M ;
PEDERSEN, NL .
BRITISH MEDICAL JOURNAL, 1986, 293 (6544) :426-426
[32]  
Ozawa A, 1982, JPN ANALYST, V31, P87
[33]   Fish oil-derived fatty acids, docosahexaenoic acid and docosapentaenoic acid, and the risk of acute coronary events -: The kuopio ischaemic heart disease risk factor study [J].
Rissanen, T ;
Voutilainen, S ;
Nyyssönen, K ;
Lakka, TA ;
Salonen, JT .
CIRCULATION, 2000, 102 (22) :2677-2679
[34]   n-3 Fatty Acids in Patients with Multiple Cardiovascular Risk Factors [J].
Roncaglioni, Maria Carla ;
Tombesi, Massimo ;
Avanzini, Fausto ;
Barlera, Simona ;
Caimi, Vittorio ;
Longoni, Paolo ;
Marzona, Irene ;
Milani, Valentina ;
Silletta, Maria Giuseppina ;
Tognoni, Gianni ;
Marchioli, Roberto .
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (19) :1800-1808
[35]   Randomized, double-blind, placebo-controlled trial of fish oil and mustard oil in patients with suspected acute myocardial infarction: The Indian experiment of infarct survival .4. [J].
Singh, RB ;
Niaz, MA ;
Sharma, JP ;
Kumar, R ;
Rastogi, V ;
Moshiri, M .
CARDIOVASCULAR DRUGS AND THERAPY, 1997, 11 (03) :485-491
[36]   DIETARY-INTAKE AND CELL-MEMBRANE LEVELS OF LONG-CHAIN N-3 POLYUNSATURATED FATTY-ACIDS AND THE RISK OF PRIMARY CARDIAC-ARREST [J].
SISCOVICK, DS ;
RAGHUNATHAN, TE ;
KING, I ;
WEINMANN, S ;
WICKLUND, KG ;
ALBRIGHT, J ;
BOVBJERG, V ;
ARBOGAST, P ;
SMITH, H ;
KUSHI, LH ;
COBB, LA ;
COPASS, MK ;
PSATY, BM ;
LEMAITRE, R ;
RETZLAFF, B ;
CHILDS, M ;
KNOPP, RH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (17) :1363-1367
[37]   Long-term treatment with eicosapentaenoic acid augments both nitric oxide-mediated and non-nitric oxide-mediated endothelium-dependent forearm vasodilatation in patients with coronary artery disease [J].
Tagawa, H ;
Shimokawa, H ;
Tagawa, T ;
Kuroiwa-Matsumoto, M ;
Hirooka, Y ;
Takeshita, A .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1999, 33 (04) :633-640
[38]   Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial [J].
Tavazzi, Luigi ;
Maggioni, Aldo P. ;
Marchioli, Roberto ;
Barlera, Simona ;
Franzosi, Maria Grazia ;
Latini, Roberto ;
Lucci, Donata ;
Nicolosi, Gian Luigi ;
Porcu, Maurizio ;
Tognoni, Gianni .
LANCET, 2008, 372 (9645) :1223-1230
[39]   Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial [J].
Thies, F ;
Garry, JMC ;
Yaqoob, P ;
Rerkasem, K ;
Williams, J ;
Shearman, CP ;
Gallagher, PJ ;
Calder, PC ;
Grimble, RF .
LANCET, 2003, 361 (9356) :477-485
[40]  
Thygesen K, 2007, EUR HEART J, V28, P2525